Article Details
Retrieved on: 2025-01-23 23:11:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Rhonda Farnum, SVP of COMM & MEDICAL AFFAIRS at Theravance Biopharma, sold 4000 Ordinary Shares on January 21, 2025, at a price of $9.0 per share, ...
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here